Marinomed Exploring Options For Virus-Blocking OTC Nasal Spray Platform

The virus-blocking platform used in OTC nasal sprays marketed by Perrigo and Reckitt, amongst others, developed by Austria's Marinomed is up for sale.

nasal spray
• Source: Shutterstock

Austrian biotech Marinomed is weighing up strategic options for its virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo, Reckitt and Procter & Gamble for use in OTC nasal sprays.

Having appointed an external advisor, Marinomed said it has initiated a process to begin engaging with interested parties to discuss...

More from Strategy

More from Business